The required need for unpaid family caregivers (FCs) is only increasing as more people age, are diagnosed with a disease, or have a disability rendering them unable to live independently. Caregiving can be incredibly rewarding. However, caregiving can be extremely detrimental on the physical and mental health, as well as financial well-being of the FC.
Nursing can improve the mental and physical health of FCs and assist with difficult decisions. They can provide program referrals for respite care. Nurse can also be the conduit of support for special FC populations, such as for military and those caring for children with special needs.
The required need for unpaid family caregivers (FCs) is only increasing as more people age, are diagnosed with a disease, or have a disability rendering them unable to live independently. Caregiving can be incredibly rewarding. However, caregiving can be extremely detrimental on the physical and mental health, as well as financial well-being of the FC. Nursing can improve the mental and physical health of FCs and assist with difficult decisions. They can provide program referrals for respite care. Nurse can also be the conduit of support for special FC populations, such as for military and those caring for children with special needs.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
Kansas State Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Michigan Board of Nursing (CEBroker Provider #50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Wyoming Board of Nursing (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Background
Types of FCs
Care Transition
Section 3: Burdens Impacting FCs
Financial
Decision-Making and Guilt
Declining Physical Health
Declining Mental Health
Section 4: Nursing Impact on FCs
Initial FC Screening by Nurse
Healthcare and ADLs
Mental Health and Respite Relief
Cultural and Socioeconomic Factors
End-of-Life and Palliative Care
Military
Special Needs
Support Animals
Section 5: Clinical Vignette
Section 6: Conclusion
Course Summary
Course Contributor
Resources
References
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.